Chapter 11: Cell Signaling by Chemical Messengers

Cell signaling comprises the molecular mechanisms through which cells perceive and respond to extracellular chemical messages, integrating these signals into coordinated physiological responses. This chapter systematizes the classification of chemical messengers including hormones, neurotransmitters, cytokines, growth factors, and eicosanoids, distinguishing their hydrophilic versus hydrophobic properties and tissue-specific delivery mechanisms. The chapter then surveys the major receptor families responsible for signal transduction. G-protein-coupled receptors activate heterotrimeric GTP-binding proteins that modulate intracellular second messengers such as cyclic adenosine monophosphate and inositol-derived molecules, amplifying extracellular signals through cascades of kinase activation. Receptor tyrosine kinases, exemplified by the insulin receptor, undergo autophosphorylation to recruit adapter proteins and activate phosphoinositide-3-kinase and mitogen-activated protein kinase cascades, ultimately governing metabolic and transcriptional outcomes. Cytokine receptors initiate Janus kinase-signal transducer and activator of transcription pathways, while transforming growth factor-beta receptors activate Smad proteins to regulate gene expression. Intracellular receptors for steroid and thyroid hormones function as ligand-dependent nuclear transcription factors that directly modulate target gene transcription. The chapter explores signal termination through phosphodiesterase activity, receptor desensitization, and endocytic internalization, and discusses cross-talk permitting integration of multiple signaling inputs. Clinical applications illuminate how signaling dysfunction produces disease: adrenergic dysregulation in anxiety disorders, leptin and ghrelin imbalance in appetite disorders, cholera toxin-mediated constitutive activation of stimulatory G-proteins in secretory diarrhea, and autoimmune-mediated loss of acetylcholine receptors in myasthenia gravis. The chapter concludes by demonstrating how targeted therapies such as tyrosine kinase inhibitors exploit signaling dependencies in malignant cells, establishing signal transduction as central to understanding both physiological regulation and pathogenic mechanisms.